Search
for
Sort by
Research 271–300 of 1000+
- The role of androgen therapy
- MiR-92a-1-5p and miR-328-3p Are Up-Regulated in Skin of Female Pattern Hair Loss Patients
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities
- Hội chứng chuyển hoá và các yếu tố liên quan ở bệnh nhân rụng tóc nội tiết tố androgen
- Hyperandrogenism insulin resistance-acanthosis nigricans syndrome in a female adolescent with migraine: A case report
- Paraoxonase Enzyme Activity and Determination of Phenotypic Polymorphism in Patients with Acne Vulgaris
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
- Comparison of Components of Metabolic Syndrome in Androgenic Alopecia versus Healthy Population
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Metabolic risk in PCOS: phenotype and adiposity impact
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Women’s Health Considerations for Lipid Management
- Polycystic ovary syndrome
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial
- Medical uses of Carthamus tinctorius L. (Safflower): a comprehensive review from Traditional Medicine to Modern Medicine
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin